Bicycle Therapeutics plc Share Price

Bicycle Therapeutics plc Share Price

NASDAQ: BCYC | Micro Cap
$3.70
-$0.11 (-3.01%) Last updated on 30 Oct, 2026 | 22:47 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Bicycle Therapeutics plc Stock Performance

Open
$3.77
Prev. Close
$3.81
Circuit Range
N/A
Day Range
$3.62 - $3.77
Year Range
$3.33 - $9.05
Volume
19,367
Average Traded
$3.69

Bicycle Therapeutics plc Share Price Today

As of 30 October 2026, Bicycle Therapeutics plc's share price is $3.70. The stock opened at $3.77, compared to its previous close of $3.81. During today's trading session, Bicycle Therapeutics plc's share price traded between $3.62 and $3.77, with an average price of $3.70. Over the past 52 weeks, the stock has recorded a high of $9.05 and a low of $3.33. In terms of performance, Bicycle Therapeutics plc's share price has declined by 21.61% over the last six months and is down 54.21% on a year-on-year basis.

Bicycle Therapeutics plc Share Price Chart

Line chart of the Bicycle Therapeutics plc price trend over the selected period. The price fell overall, ranging from 3.62 to 3.81, ending at 3.70.
$3.62$3.77
L
Show Current Price
H

Bicycle Therapeutics plc Stock Fundamentals & Key Indicators

Market Cap
$256.34M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.02
Revenue (TTM)
$72.59B
Return On Equity (TTM)
-28.06%
Profit Margin
-301.64%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
14.84%

Bicycle Therapeutics plc Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$11.73$47.96$0.89$0.63
Net Profit-$59.10-$20.15-$60.83-$50.33
Net Profit Margin-503.84%-42.01%-6834.83%-7988.89%
Income ChangeN/A65.91%-201.89%17.26%

Bicycle Therapeutics plc Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$14.46$26.98$35.28$72.59
Net Profit-$112.72-$180.66-$169.03-$218.96
Net Profit Margin-779.53%-669.61%-479.11%-301.64%
Income ChangeN/A-60.27%6.44%-29.54%

About Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Bicycle Therapeutics plc Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.67
$3.71
+0.27%
Sep 2026
$4.11
$3.69
-14.67%
Aug 2026
$3.83
$4.33
+12.03%
Jul 2026
$4.29
$3.87
-9.06%
Jun 2026
$4.58
$4.25
-9.57%
May 2026
$4.71
$4.70
-0.42%
Apr 2026
$4.72
$4.72
+2.05%
Mar 2026
$5.68
$4.63
-19.43%
Feb 2026
$6.38
$5.74
-10.52%
Jan 2026
$7.09
$6.42
-9.01%
Dec 2025
$7.25
$7.05
-5.94%
Nov 2025
$8.04
$7.50
-7.24%

BCYC Share Price FAQs